BPGbio’s Biomarker Panel for Parkinson’s Gets Clinical Validation
A Parkinson’s disease biomarker panel successfully combines N-acetylputrescine with specific clinical features as a predictor of PD.
Read MorePosted by Andy Lundin | May 20, 2024 | Diagnostic Technologies |
A Parkinson’s disease biomarker panel successfully combines N-acetylputrescine with specific clinical features as a predictor of PD.
Read MorePosted by Chris Wolski | May 15, 2024 | Dementias & Alzheimer’s |
A study has identified a new biomarker for asymptomatic Alzheimer’s disease, potentially enabling earlier diagnosis and treatment.
Read MorePosted by Chris Wolski | Apr 30, 2024 | Allergy & Autoimmune |
The personal journey of co-author and physician Dana Mitchell details the challenges of accurate diagnosis of autoimmune encephalitis.
Read MorePosted by Andy Lundin | Mar 20, 2024 | Dementias & Alzheimer’s |
A skin biopsy can detect an abnormal form of alpha-synuclein, the pathological hallmark of Parkinson’s disease, at high positivity rates.
Read MorePosted by Andy Lundin | Feb 5, 2024 | Dementias & Alzheimer’s |
Researchers have developed a tool that could help monitor Alzheimer’s progression or distinguish between different amyloid-related conditions.
Read More